2010
DOI: 10.1504/ijbt.2010.036594
|View full text |Cite
|
Sign up to set email alerts
|

Development and characterisation of sodium alginate and HPMC films for mucosal drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
4
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 9 publications
1
4
0
Order By: Relevance
“…Recent years have seen similar studies carried out by many other workers [93] – [96] . Table 1 showcases some of the most worked upon APIs in the field of MBDDS along with the polymers associated, and Table 2 enlists some commercially available dosage forms meant to be applied in the buccal cavity along with their therapeutic application.…”
Section: A Clinical/therapeutic Approachsupporting
confidence: 76%
“…Recent years have seen similar studies carried out by many other workers [93] – [96] . Table 1 showcases some of the most worked upon APIs in the field of MBDDS along with the polymers associated, and Table 2 enlists some commercially available dosage forms meant to be applied in the buccal cavity along with their therapeutic application.…”
Section: A Clinical/therapeutic Approachsupporting
confidence: 76%
“…In addition, % elongation at break represents the strain magnitude responsible for the film elongation. 19 Remarkably, polymeric films manifest an opposite relationship between tensile strength and % elongation. Hence, applying the tensile strength test to evaluate the film's elasticity is important in the integrity of the film that is favorable to be intact one piece.…”
Section: Tensile Strengthmentioning
confidence: 99%
“…Modified forms of such hydrogel polymers with better bioadhesivity create second-generation mucosal dosage forms [9]. In the present study, we report on the development of solvent cast films for buccal delivery in paediatric patients using various hydrogel polymers generally regarded as safe (GRAS) and used in mucosal formulations [10][11][12][13] including HPMC, MC, CA, MET, SA, plasticiser (PEG 400), OME (model drug) and L-arg (to stabilise OME). Various parameters such as drying times and temperatures, casting solvents as well as polymer and plasticiser concentrations were investigated and the films subsequently characterised as part of the development and optimisation.…”
Section: Introductionmentioning
confidence: 99%